Treatment Chronic UTI Post Kidney Transplant

Summary

Urinary tract infections (UTIs) with extended-spectrum -lactamase (ESBL)-positive Enterobacteriums (ESBL-E) are a common infectious complication of renal transplant recipients, with 10% of patients suffering from UTIs with ESBL-E within the first year posttransplant. Moreover, recurrence rates of UTI caused by ESBL-E are almost three times higher than those by cephalosporin-susceptible Enterobacteriums demonstrating the decreased efficacy of antibiotics in the treatment of these UTIs.

Timeline

Start

2023-07-01

Primary completion

2024-01-01

Completion

2024-07-01

Outcome

Outcome not reported

Stopped: “drug not provided”

Drugs

Indications